Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for the Treatment of Systemic Sclerosis
NCT03365869Phase 2Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jun 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of sirolimus in systemic sclerosis (SSc), sponsored by Peking University People's Hospital. Status: unknown.
02
Drugs
sirolimus
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT03365869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03365869.